Navigation Links
EPSScentral Responds to Pandemic Alert
Date:5/4/2009

ANNANDALE, Va., May 4 /PRNewswire/ -- EPSScentral LLC today announced its readiness to assist organizations in assembling, communicating, and implementing mitigation measures in the face of WHO's phase 5 classification of the Influenza A crisis. According to the WHO, phase 5 "...is a strong signal that a pandemic is imminent and that the time to finalize... mitigation measures is short."

(Logo: http://www.newscom.com/cgi-bin/prnh/20080701/DC26612LOGO)

A world leader in ensuring organizational competency and performance, EPSScentral, together with pandemic content experts and technology partners, developed a package to address pandemic planning needs. Commencing with the SARS and Avian Flu crises over the past two years, EPSScentral developed the solution as a component of its process improvement and standard operating procedures practices. According to President and CEO Gary J. Dickelman, "It is socially responsible at this time to communicate our rapid, innovative approach to mitigating business disruption caused by Influenza A, especially in these challenging economic times. Having a solid plan in place mitigates overreacting to pandemic press. It prevents unnecessary business disruption while addressing the health and safety of employees in measured and responsible ways."

EPSScentral's offering includes: A baseline, easily customizable pandemic contingency plan; a set of templates and tools for rapid localization and deployment; resources to jump-start customization; and access to additional expert knowledge as the Influenza A (aka H1N1, Swine Flu) or other pandemic scenarios evolve. A sample EPSScentral pandemic plan can be viewed at http://pandemic.epssnews.com.

EPSScentral LLC is known for quality solutions that provide explicit, accessible and usable end-to-end best-practice processes; accelerate development and rollout by up to 80%; decrease time-to-competency; and foster remarkable returns on investment. Since 2002, the Company has provided thought leadership and mission critical solutions that transform business and assure the organizational mission at the speed of work. A hallmark is EPSScentral's ability to reduce organizational complexity as processes grow and supporting technologies evolve. Using EPSScentral's approach, their large private and public sector clients typically realize a ten-fold return on investment. Contact Shirah Cohen, VP, at scohen@epsscentral.net, 703-851-0545 and visit http://www.epsscentral.net.


'/>"/>
SOURCE EPSScentral LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. AstraZeneca Responds to FDA Joint Advisory Committees Recommendation on SYMBICORT(R)
2. GSK Believes There Is No Liver Safety Issue With AVANDIA; Responds to Public Citizen Petition
3. GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval
4. Roche responds to announcement of IDEAL hepatitis C trial results
5. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
6. USAID Cooperates in Pandemic Preparedness Initiative
7. Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate
8. Novavax Presents Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program at World Health Organization Conference
9. USD 12.5 m Funding for the Development of Intercells Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
10. Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans
11. Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... 2017 Precision medicine is an emerging ... of disease. The approach allows doctors and physicians ... The approach studies the individual profile at a ... In January 2015, Precision Medicine Initiative (PMI) was ... with more than one million volunteers. All of ...
(Date:1/17/2017)... -- Research and Markets has announced the addition of ... to their offering. ... The global artificial pancreas devices system market to grow at ... Artificial Pancreas Devices System Market 2016-2020, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
(Date:1/17/2017)... Jan. 17, 2017 The interventional radiology products ... 2021 from USD 6.35 billion in 2016, at a ... growth of this market are rising incidence of chronic ... invasive surgeries. The global interventional radiology products ... region. On the basis of type, the stents segment ...
Breaking Medicine Technology:
(Date:1/18/2017)... ... January 18, 2017 , ... The VA ... are collaborating on a research project focused on multiple sclerosis (MS). Led by ... use nanotechnology to control the disease without compromising normal immune function that often ...
(Date:1/18/2017)... ... 18, 2017 , ... The V Foundation for Cancer Research, a top-rated cancer ... and fundraising team, to compete in the Boston Marathon on April 17. From ... world’s oldest annual marathon to join Team V and support the Foundation’s mission to ...
(Date:1/18/2017)... ... 2017 , ... The Portee Insurance Agency, a family managed firm that offers ... and the DC region, is inaugurating a charity event aimed at fighting heart disease ... it the #1 killer in America. However, heart disease is largely preventable, and a ...
(Date:1/18/2017)... ... January 18, 2017 , ... Dr. Farhan Qureshi is an ... implants dentistry. His modern dental practice has two convenient office locations in Alexandria and ... Rated Dentist for the Alexandria area. This award confirms the fact that ...
(Date:1/18/2017)... ... January 18, 2017 , ... The Hear ... aid project with the donation of cochlear implants. In February 2017, the first ... thus a fair chance of leading an independent life. This engagement builds on ...
Breaking Medicine News(10 mins):